Inhibiting the polyol pathway with specific inhibitors restored SIRT2 expression and improved mitochondrial function, suggesting that enhancing SIRT2 signaling could be a potential therapeutic strategy for diabetic neuropathy [29]. This evidence concerns the gene SIRT2 and diabetic neuropathy.